42 results
8-K
EX-99.1
PSTX
Poseida Therapeutics Inc
1 May 24
Entry into a Material Definitive Agreement
9:07am
Rx+® healthcare solutions that combine our expertise and knowledge with cutting-edge technology in different fields of external partners. Through … these efforts, Astellas stands on the forefront of healthcare change to turn innovative science into VALUE for patients. For more information, please
8-K
EX-10.1
bqopf8w
7 Aug 23
Astellas and Poseida Therapeutics Announce Strategic
9:01am
8-K
EX-99.1
2dt1qc28y6in
7 Aug 23
Astellas and Poseida Therapeutics Announce Strategic
9:01am
8-K
EX-1.1
efw 0srvj1828z
4 Aug 22
Poseida Therapeutics Announces Proposed Public Offering of Common Stock
4:57pm
S-3
EX-1.2
2roxcwwm8hnt n6rcrvv
13 Aug 21
Shelf registration
4:13pm
8-K
EX-99.1
om3 mn79jj
12 Aug 21
Poseida Therapeutics Reports Program Updates and Financial Results for the Second Quarter of 2021
4:25pm